These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38131248)

  • 1. The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry.
    Tomasoni D; Vitale C; Guidetti F; Benson L; Braunschweig F; Dahlström U; Melin M; Rosano GMC; Lund LH; Metra M; Savarese G
    Eur J Heart Fail; 2024 Apr; 26(4):854-868. PubMed ID: 38131248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure Registry.
    Settergren C; Benson L; Shahim A; Dahlström U; Thorvaldsen T; Savarese G; Lund LH; Shahim B
    Eur J Heart Fail; 2024 May; 26(5):1150-1159. PubMed ID: 38606645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
    Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failure.
    Wolsk E; Claggett B; Køber L; Pocock S; Yusuf S; Swedberg K; McMurray JJV; Granger CB; Pfeffer MA; Solomon SD
    Eur J Heart Fail; 2018 Mar; 20(3):504-510. PubMed ID: 29193462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
    Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
    Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS; Tay WT; Teng THK; Vedin O; Benson L; Dahlstrom U; Savarese G; Lam CSP; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Savarese G; Xu H; Trevisan M; Dahlström U; Rossignol P; Pitt B; Lund LH; Carrero JJ
    JACC Heart Fail; 2019 Jan; 7(1):65-76. PubMed ID: 30553905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
    Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
    J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden death in heart failure with preserved ejection fraction and beyond: an elusive target.
    Manolis AS; Manolis AA; Manolis TA; Melita H
    Heart Fail Rev; 2019 Nov; 24(6):847-866. PubMed ID: 31147814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction.
    Liu D; Hu K; Schregelmann L; Hammel C; Lengenfelder BD; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2023 Apr; 10(2):1358-1371. PubMed ID: 36732921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of comorbidities on the prognosis after an acute heart failure decompensation and differences according to ejection fraction: Results from the EAHFE and RICA registries.
    Miró Ò; Conde-Martel A; Llorens P; Salamanca-Bautista P; Gil V; González-Franco Á; Jacob J; Casado J; Tost J; Montero-Pérez-Barquero M; Alquézar-Arbé A; Trullàs JC;
    Eur J Intern Med; 2023 May; 111():97-104. PubMed ID: 36914535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
    Chioncel O; Benson L; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; McDonagh T; Margineanu C; Mebazaa A; Metra M; Piepoli MF; Adamo M; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Volterrani M; Ferrari R; Maggioni AP; Lund LH
    Eur J Prev Cardiol; 2023 Sep; 30(13):1346-1358. PubMed ID: 37172316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of NT-proBNP as a prognostic marker of all-cause mortality in patients with heart failure with preserved and mid-range ejection fraction in primary care: A report from the swedish heart failure register.
    Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
    Scand J Prim Health Care; 2019 Dec; 37(4):434-443. PubMed ID: 31724475
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient profile and outcomes associated with follow-up in specialty vs. primary care in heart failure.
    Lindberg F; Lund LH; Benson L; Schrage B; Edner M; Dahlström U; Linde C; Rosano G; Savarese G
    ESC Heart Fail; 2022 Apr; 9(2):822-833. PubMed ID: 35170237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in N-Terminal Pro-Brain Natriuretic Peptide Levels Are Associated With Lower Mortality and Heart Failure Hospitalization Rates in Patients With Heart Failure With Mid-Range and Preserved Ejection Fraction.
    Savarese G; Hage C; Orsini N; Dahlström U; Perrone-Filardi P; Rosano GM; Lund LH
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 28029640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.